Rebecka Rubenson Wahlin

Statistics

Publications

Citations

705

H-Index

Active since

2016

Affiliations

Karolinska Institutet(Current)

Stockholm South General Hospital

Slagelse Hospital

The George Institute for Global Health

Homi Bhabha National Institute

Rebecka Rubenson Wahlin is an author at Karolinska Institutet specializing in pharmacotherapy, prehospital emergency care, and corticosteroid therapy.

ORCID

Publications per year

2016–2024

Publications

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

Lene Russell, Kis Rønn Uhre, Ann Louise Syraach Lindgaard et al. · JAMA · 2021 · 263 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Anders Granholm, Marie Warrer Munch, Sheila Nainan Myatra et al. · Intensive Care Medicine · 2021 · 122 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial

Marie Warrer Munch, Tine Sylvest Meyhoff, Marie Helleberg et al. · Acta Anaesthesiologica Scandinavica · 2021 · 57 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +12

Do male and female trauma patients receive the same prehospital care?: an observational follow-up study

Rebecka Rubenson Wahlin, Sari Ponzer, Hanna K Lövbrand et al. · BMC Emergency Medicine · 2016 · 53 citations · Full text

Medicine, Emergency Medicine, Pediatric Emergency Care +16

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan

Marie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg et al. · Acta Anaesthesiologica Scandinavica · 2020 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1–5 of 15